← Leaderboards
Julius Strauss
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Safety”
- David Heimbrook · Leidos Biomedical Research, Inc.$398,099,186
- Lawrence Corey · Fred Hutchinson Cancer Center$396,952,463
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- Gary D Acton · University Of California-Davis$320,373,312
- Melynda Holmes · Technical Resources Inc$232,659,786
- Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Research focus
SafetyToxic EffectMalignant NeoplasmsResponseImmunotherapeutic AgentSolid NeoplasmImmunotherapyInterestProgramsRecombinant VaccinesChimeric ProteinsClinical TrialsEvaluationImmunologicsCytotoxic AgentImmune Checkpoint InhibitorCollaborationsConduct Clinical TrialsAnemiaMultidisciplinaryCancer ImmunotherapyDoseAreaTransforming Growth Factor Beta
Grant awards (7)
Cancer Immunotherapy Clinical Trials$1,516,058
ZIA · FY2023 · CA · contact PI
Cancer Immunotherapy Clinical Trials$1,168,320
ZIA · FY2022 · CA · contact PI
Cancer Immunotherapy Clinical Trials$902,872
ZIA · FY2021 · CA · contact PI
Cancer Immunotherapy Clinical Trials$612,359
ZIA · FY2020 · CA · contact PI
Cancer Immunotherapy Clinical Trials$472,182
ZIA · FY2019 · CA · contact PI
Cancer Immunotherapy Clinical Trials$890,340
ZIA · FY2018 · CA · contact PI
Cancer Immunotherapy Clinical Trials$458,587
ZIA · FY2017 · CA · contact PI